38,159 hospitals
At end-2025: 11,678 public and 26,481 private hospitals. Their budgets, evaluation and procurement processes need separate research.
CHINA MEDICAL DEVICE B2B MARKETINGSource: National Health Commission, 2025 statistics. Health expenditure is a preliminary estimate for the whole health system, not the medical-device market.
Entering China’s Healthcare Market? Establish Your Product Route Before Marketing.
General products and medical devices follow different requirements. B2B positioning or overseas certification does not automatically permit promotion in China. We map marketing readiness around intended use, classification and existing China credentials; your regulatory specialists confirm classification and market access.
38,159Hospitals
1.06 millionPrimary-care institutions
RMB 9.34 trillionAnnual health expenditure
Ad management: L1 Standard USD 800 or L2 Professional USD 1,500 per platform / month. Choose one plan. Media, content, PR and human support are separate.
Platforms are selected to match the project. Logos identify platforms, not an official partnership status.
China’s healthcare scale: identify the relevant buyer
1.06 million primary-care institutions
1,056,534 at end-2025, including clinics and village health rooms. These are not equally equipped buyers or equivalent procurement opportunities.
RMB 9.34 trillion in health expenditure
2025 preliminary estimate: RMB 9,336.72 billion across the health system. This is not medical-device sales or an addressable import market.
Source: National Health Commission, 2025 Statistical Communiqué on Health Development, published 28 August 2026. These 2025 measures include a preliminary health-expenditure estimate and provide context, not live 2026 demand.
China is not a single procurement channel
End users · Public, private and primary care
Choose the specialty, application and institution type. Check budgets, technical evaluation, purchasing procedures and any applicable centralised procurement arrangements.
Channels · Import, distribution and local service
Separate filing / registration responsibilities from selling and servicing roles. Assess lawful operation, regional coverage, professional support, logistics and after-sales capability.
Supply chain · Manufacturers and OEM buyers
Components, materials and manufacturing services address device-company R&D, purchasing and quality teams. Assess the product’s own regulatory status as well as customer qualification requirements.
A project-planning framework, to be checked against product, region, institution and procurement requirements. PPCOps does not guarantee registration, ad approval or hospital tender awards.
Two product routes—not a choice of marketing labels
Route 1 · Confirmed general products
Some general components, non-medical equipment or services may follow a general-product route after intended use and classification are confirmed. Applicable import, quality, certification and business requirements still apply. Do not make disease-treatment claims.
Route 2 · Medical devices under Chinese rules
Class I devices generally require product filing; Classes II and III require registration. Imported devices have an import route and domestic responsibility arrangements. Selling, advertising and platform conditions remain separate checks. Drugs, disinfection products and other categories need their own assessment.
Separate checks: product access, operator and advertising
Product access
Specialists confirm classification, intended use and applicable filing / registration. Overseas certification is not Chinese market authorisation.
Operating entity
Check the actual seller and scope. Class II distribution generally requires filing, with statutory exceptions; Class III generally requires a licence. A distributor label is not sufficient.
Permitted promotion
Medical-device advertising requires statutory pre-publication review. Product registration, ad review and platform checks are separate. Keep claims within permitted scope; B2B positioning does not remove review obligations.
Policy basis: current Medical Device Supervision and Administration Regulation, Articles 13, 41, 42 and 60; PRC Advertising Law, Articles 17 and 46. This is route guidance; your regulatory specialists confirm the product-specific requirements.
Plan China marketing after the applicable conditions are clear
Separate business demand from patient searches
Define distributors, institutional procurement or device-company buyers. Review search intent to reduce consumer, symptom and unrelated treatment enquiries.
Prepare approved Chinese communications
Work from product information and claims approved by your responsible team. Scope localisation, technical landing content and professional media around the agreed audience.
Execute and review relevant responses
Confirm the applicable account and platform conditions before advertising. Report enquiry relevance and agreed delivery; use sales feedback or separately scoped telephone checks.
A channel plan matched to the product—not a blanket medical campaign
Search: product and professional procurement intent
Consider suitable product, equipment and business-buyer searches after the account route and permitted materials have been reviewed.
WeChat & relevant media: professional communication
Use approved product explanations and company information to support distributor and professional-buyer evaluation. Content and PR can be scoped independently.
Technical content: answer buyer questions
Explain intended application, product range, supporting materials and the enquiry process. Technical, clinical and regulatory claims remain subject to client specialist review.
For medical-technology businesses and their agency partners
Device & equipment manufacturers
IVD, laboratory equipment, imaging, surgical and rehabilitation products. Define the intended buyer and product application before selecting channels.
Medical components & OEM suppliers
Sensors, electronics, precision parts and specialist manufacturing for device businesses. Reach relevant sourcing, engineering and product teams.
Healthcare & PR agencies
Localise an approved China brief and coordinate content, media and campaign execution. Keep client ownership, review responsibilities and reporting clear.
Start with a clear commercial brief
Product & intended use
Device category, intended application, product website and available approved materials.
Buyer & market route
Distributor, professional procurement or OEM buyer; China market status and intended regions.
Resources & responsibilities
Who approves content, answers technical questions and follows up the enquiry; timing and budget.
This is a B2B marketing service, not patient acquisition or regulatory registration. Do not submit patient records or personal medical information through the enquiry form. Acceptance and scope are assessed before launch.
From advertising to sales and channels: what each stage delivers
Reach relevant buyers through paid campaigns, then use enquiry quality and real feedback to decide whether local commercial support makes sense. L1–L5 describe service scopes, not a compulsory five-part package.
01 · Advertise & optimise
Choose L1 or L2
L1
Standard ad execution
Set up, manage and optimise campaigns on selected platforms, with agreed reporting.
L2
L2 · Professional management
Combine campaign work with industry information and lead-quality feedback supplied by your brand team or separately purchased L3 checks.
02 · Check lead quality
Add L3 when needed
L3
Human telephone qualification
Confirm the lead’s company and contact details, relevance of the requirement and initial intent. Hand over contact outcomes and lead-quality labels.
Lead-quality checks only: not ongoing sales follow-up, quotation negotiations or order chasing.
From USD 800 / month · agreed contact capacity
03 · Develop sales & channels
Assessed after campaign testing and L3 checks
L4
Local sales representation
Authorised buyer communication, meetings, quotation coordination and opportunity follow-up.
L5
Distributor, agent & channel development
Define channel criteria, research and contact potential partners, and coordinate introductions and follow-up.
Custom quote for industry, workload and authority
L2 replaces L1; the two are not charged together. Projects seeking L4 or L5 also start with L1 or L2 campaign testing, quality feedback and L3 lead checks. Further support depends on relevant demand, quotation acceptance, delivery feasibility and the resources both teams can commit.
Brand communications, PR, content and account operations remain separately scoped services. They can support a B2B campaign without committing your brand to a sales-follow-up programme.
CLEAR FEES
Choose the advertising support you need.
L1 · Standard ad execution
USD 800
per platform / month
Campaign preparation, agreed ad management, optimisation and reporting. Media funding is separate.
Professional ad management
USD 1,500
per platform / month
Campaign management with industry information and lead-quality feedback from your team or separately purchased L3 checks, applied to optimisation.
Advertising only: media funding is additional
Initial media funding per platform: from USD 1,500 for mainland-China entities; from USD 7,500 for entities registered outside mainland China. PPCOps offers are subject to eligibility and the confirmed account route.
Professional replaces Standard for the same platform and month. Neither plan includes human telephone qualification.
Three-month option & additional costs
Recommended, not mandatory: USD 12,000 for one platform over three months. USD 7,500 media funding + USD 4,500 Professional management (3 × USD 1,500). Optional human support and other quoted costs are additional.
Standalone account setup starts at USD 300; the setup service fee may be waived with agreed media funding and management or other services. Translation, certification and other actual third-party costs are confirmed separately. Basic Chinese landing-page support depends on scope; complex custom work starts from USD 800.
Multi-platform discounts can be discussed. Deliverables, revisions, external costs and media balance arrangements are confirmed in the quote and contract.
Content and communications, scoped to your needs
PR / media publishing from USD 500. Chinese content, account operations and custom production are quoted by scope. L3 telephone checks start at USD 800 / month with agreed capacity. L4 / L5 are quoted for the industry, workload and authority, separately from ad management.
See the service pricing catalogue →Measure delivery, enquiry quality and commercial progress separately
Professional relevance
Separate business buyers and partners from patient, consumer and unrelated requests.
Enquiry quality
Record the product interest, buyer role and next question that your team needs to answer. A media view is not a procurement opportunity.
Progress after handover
Use your team’s feedback on technical review, quotations and partner discussions. Marketing does not guarantee hospital orders or distributor agreements.
Confirm the conditions, then execute
Share product information
Intended use, classification, China credentials and buyer
Confirm requirements
Your specialists verify access, operator and permitted claims
Agree execution
Scope content, media and campaigns within applicable approvals
Report and hand over
Separate enquiries, partner evaluation and purchasing progress
EXPERIENCE · EXECUTION · ACCOUNTABILITY
Why PPCOps
18 Years in Advertising
Turn business needs and agency briefs into content, advertising and media execution.
8 Years in Industrial Trade
Trade in industrial parts, MRO, apparel, solar and automotive parts across the US, Europe (including the UK), UAE, Canada, Singapore and Australia.
China Team for Brands & Agencies
A China-based team for global brands and PR agencies: brand building, paid ads, industrial enquiry forms and e-commerce operations, aligned with your brief and approvals.
Flexible Service Scope
Commission planning, content, publishing and advertising together, or divide the work with your team.
Clear Fees & Deliverables
Agree scope, fees and approvals before work starts, with reporting matched to the delivery.
Feedback-led Optimisation
Use campaign response and relevant enquiry feedback to adjust content and advertising around your goals.
Selected Brand Experience · Industrial & Technology First
Selected brand project experience. Discuss the relevant scope of work with us; brand names do not imply endorsement, sector-specific sales results or a promise of similar outcomes.
Siemens
ABB
Schneider Electric
Huawei
HP
BYD
BMW
Mercedes-Benz
Lexus
Xiaomi
Tesla
Hang Seng Bank
Other brand experience (12)
Chanel
Louis Vuitton
HSBC
Starbucks
MUJI
China Merchants Bank
KFC
Estée Lauder
Mannings Hong Kong
Watsons
UNIQLO
Marks & Spencer
Questions before you start
Can we choose to enter as a general product?
No. Intended use, function, claims and Chinese classification rules determine the applicable route. Renaming the product or calling it B2B does not remove regulatory obligations.
Does overseas certification replace Chinese credentials?
Do not assume so. Product access, operating requirements, advertising review and platform checks are separate. Your regulatory specialists must confirm the route for the actual product.
Are general products free of qualification requirements?
No. Applicable quality, import, certification, business and advertising rules still need checking. General-product promotion must not make disease-treatment claims.
Do you provide device registration or legal opinions?
No. PPCOps provides agreed marketing execution and coordination. We do not issue classification decisions, registrations, licences or legal opinions.
Can we start ads immediately or expect guaranteed hospital orders?
No. Establish the product and channel conditions, complete applicable reviews and prepare permitted content before assessing launch. Registration, advertising approval, platform acceptance and procurement are separate decisions; none is a guaranteed sale.
What can we do before China registration or filing is complete?
Prepare product information, research the market and channels, and confirm applicable requirements. Preliminary research is not permission to sell or publish product ads. Have your specialists assess each proposed external activity and message.
Should we approach hospitals or distributors first?
Start with intended use, specialty, purchasing process and local support capacity. Direct institutional engagement and distributor-led access are different routes. Clarify import responsibilities, operating credentials, territory and after-sales roles.
How do you assess a relevant healthcare B2B enquiry?
Separate patient and individual retail requests from professional purchasing and channel interest. Record the organisation, contact role, product application, need and next action. Technical evaluation, partner discussions, quotations and orders are distinct stages.
Are registration, ad management and media funding bundled?
No. PPCOps does not provide registration approval or legal opinions. Current ad management is USD 800 per platform per month for L1 or USD 1,500 for L2, not both. Media, content, specialist regulatory services and human support are separate; execution remains subject to product and platform conditions.
What should we prepare for the first discussion?
Share product name and use, instructions, confirmed China classification, filing / registration status, intended operator, professional buyer and approval owner. Identify unresolved items honestly. Do not submit patient records or personal health information.
LET’S DISCUSS YOUR PROJECT
Discuss Your Product and China Entry Route
Share the intended use, target buyer, confirmed China classification and current filing / registration status. If classification is unresolved, say so. Do not submit patient records or personal medical information.